Related references
Note: Only part of the references are listed.Intestinal farnesoid X receptor puts a fresh coat of wax on fatty liver
Iina Tuominen et al.
HEPATOLOGY (2015)
Chronic Activation of FXR in Transgenic Mice Caused Perinatal Toxicity and Sensitized Mice to Cholesterol Toxicity
Qiuqiong Cheng et al.
MOLECULAR ENDOCRINOLOGY (2015)
Characterization of Distinct Subpopulations of Hepatic Macrophages in HFD/Obese Mice
Hidetaka Morinaga et al.
DIABETES (2015)
Intestinal farnesoid X receptor signaling promotes nonalcoholic fatty liver disease
Changtao Jiang et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors
Elisa Gomez Perdiguero et al.
NATURE (2015)
M2 Kupffer Cells Promote M1 Kupffer Cell Apoptosis: A Protective Mechanism Against Alcoholic and Nonalcoholic Fatty Liver Disease
Jinghong Wan et al.
HEPATOLOGY (2014)
FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation
Jun Yao et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice
Matthew J. Potthoff et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2013)
Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease
Rachel H. McMahan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
FXR signaling in the enterohepatic system
Tsutomu Matsubara et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2013)
From NAFLD to NASH to cirrhosis - new insights into disease mechanisms
Alexander Wree et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2013)
Non-alcoholic fatty liver disease (NAFLD): a tale of fat and sugar?
Lisa Longato
FIBROGENESIS & TISSUE REPAIR (2013)
Natural killer cell recognition and killing of activated hepatic stellate cells
Joan Claria
GUT (2012)
The epidemiology, pathogenesis and histopathology of fatty liver disease
Adam P. Levene et al.
HISTOPATHOLOGY (2012)
Inflammasomes in liver diseases
Gyongyi Szabo et al.
JOURNAL OF HEPATOLOGY (2012)
Bile Acid Binding Resin Improves Metabolic Control through the Induction of Energy Expenditure
Mitsuhiro Watanabe et al.
PLOS ONE (2012)
A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells
Christian Schulz et al.
SCIENCE (2012)
Animal models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis
Yoshihisa Takahashi et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Role of cytokines and chemokines in non-alcoholic fatty liver disease
Vincent Braunersreuther et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
TGR5 potentiates GLP-1 secretion in response to anionic exchange resins
Taoufiq Harach et al.
SCIENTIFIC REPORTS (2012)
Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults
G. Vernon et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Lipotoxicity and steatohepatitis in an overfed mouse model for non-alcoholic fatty liver disease
Ingrid C. Gaemers et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2011)
Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
Michael R. Charlton et al.
GASTROENTEROLOGY (2011)
The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation
Thijs W. H. Pols et al.
JOURNAL OF HEPATOLOGY (2011)
Impact of CD1d Deficiency on Metabolism
Maya E. Kotas et al.
PLOS ONE (2011)
Bile Acid Sequestrants for Lipid and Glucose Control
Bart Staels et al.
CURRENT DIABETES REPORTS (2010)
Independent Predictors of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
Noreen Hossain et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2009)
Treatment of nonalcoholic steatohepatitis with colestimide
Makiko Taniai et al.
HEPATOLOGY RESEARCH (2009)
Diagnostic value of a group of biochemical markers of liver fibrosis in patients with non-alcoholic steatohepatitis
C. Rinaldi A. Lesmana et al.
JOURNAL OF DIGESTIVE DISEASES (2009)
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
Curtis K. Argo et al.
JOURNAL OF HEPATOLOGY (2009)
Bile acids: regulation of synthesis
John Y. L. Chiang
JOURNAL OF LIPID RESEARCH (2009)
Farnesoid X Receptor Deficiency Induces Nonalcoholic Steatohepatitis in Low-Density Lipoprotein Receptor-Knockout Mice Fed a High-Fat Diet
Bo Kong et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2009)
IL-6 Deficiency Attenuates Murine Diet-Induced Non-Alcoholic Steatohepatitis
Emmanuel Mas et al.
PLOS ONE (2009)
Analyzing real-time PCR data by the comparative C-T method
Thomas D. Schmittgen et al.
NATURE PROTOCOLS (2008)
Targeting bile-acid signalling for metabolic diseases
Charles Thomas et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ
John P. Iredale
JOURNAL OF CLINICAL INVESTIGATION (2007)
Prevention and treatment of obesity, insulin resistance, and diabetes by bile acid-binding resin
Misato Kobayashi et al.
DIABETES (2007)
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity
Hajime Kanda et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
Mouse models in non-alcoholic fatty liver disease and steatohepatitis research
QM Anstee et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2006)
Free fatty acids promote hepatic lipotoxicity by stimulating TNF-α expression via a lysosomal pathway
AE Feldstein et al.
HEPATOLOGY (2004)
Bile acid binding to sevelamer HCl
W Braunlin et al.
KIDNEY INTERNATIONAL (2002)
Liver fibrosis in overweight patients
V Ratziu et al.
GASTROENTEROLOGY (2000)
Share Paper
